Actively Recruiting
Is MIO-RSA Noninferior to BIO-RSA When it Comes to Mechanical Implant Stability?
Led by Lovisenberg Diakonale Hospital · Updated on 2023-11-07
20
Participants Needed
1
Research Sites
487 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
This clinical trial will investigate whether metallic lateralization in reverse shoulder arthroplasty is as stable as bony lateralization during the first two postsurgical years, measured with CT-based motion analysis (CTMA).
CONDITIONS
Official Title
Is MIO-RSA Noninferior to BIO-RSA When it Comes to Mechanical Implant Stability?
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Eligible for primary reverse shoulder arthroplasty due to osteoarthritis, massive rotator cuff tear, failed rotator cuff repair, or post-instability osteoarthritis
- Presence of massive glenoid medialization
- Ability to read or write Norwegian
You will not qualify if you...
- Severe osteoporosis
- Osteonecrosis of the humeral head
- Dementia
- Poor deltoid function
- Revision surgery
- ASA physical status classification IV
- Suspected chronic infection
- Acute fracture
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Lovisenberg Diaconal Hospital
Oslo, Norway, 0456
Actively Recruiting
Research Team
C
Christian Owesen, PhD
CONTACT
H
Hanne Fuglø, MPTh
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
DOUBLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here